- Home
- AVIR vs MTRX Comparison
AVIR vs MTRX Comparison
Compare AVIR & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- MTRX
- Stock Information
- Founded
- AVIR 2012
- MTRX 1984
- Country
- AVIR United States
- MTRX United States
- Employees
- AVIR N/A
- MTRX N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- MTRX Engineering & Construction
- Sector
- AVIR Health Care
- MTRX Consumer Discretionary
- Exchange
- AVIR Nasdaq
- MTRX Nasdaq
- Market Cap
- AVIR 273.7M
- MTRX 327.8M
- IPO Year
- AVIR 2020
- MTRX 1990
- Fundamental
- Price
- AVIR $2.97
- MTRX $12.22
- Analyst Decision
- AVIR Hold
- MTRX Strong Buy
- Analyst Count
- AVIR 1
- MTRX 1
- Target Price
- AVIR $6.00
- MTRX $20.00
- AVG Volume (30 Days)
- AVIR 441.1K
- MTRX 184.7K
- Earning Date
- AVIR 05-12-2025
- MTRX 05-07-2025
- Dividend Yield
- AVIR N/A
- MTRX N/A
- EPS Growth
- AVIR N/A
- MTRX N/A
- EPS
- AVIR N/A
- MTRX N/A
- Revenue
- AVIR N/A
- MTRX $742,408,000.00
- Revenue This Year
- AVIR N/A
- MTRX $9.98
- Revenue Next Year
- AVIR N/A
- MTRX $20.42
- P/E Ratio
- AVIR N/A
- MTRX N/A
- Revenue Growth
- AVIR N/A
- MTRX N/A
- 52 Week Low
- AVIR $2.46
- MTRX $8.61
- 52 Week High
- AVIR $4.15
- MTRX $15.75
- Technical
- Relative Strength Index (RSI)
- AVIR 56.05
- MTRX 49.59
- Support Level
- AVIR $2.78
- MTRX $12.05
- Resistance Level
- AVIR $3.03
- MTRX $12.58
- Average True Range (ATR)
- AVIR 0.17
- MTRX 0.47
- MACD
- AVIR 0.03
- MTRX -0.07
- Stochastic Oscillator
- AVIR 88.03
- MTRX 31.58
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.